Avapritinib Carries the Risk of Drug Interaction via Inhibition of UDP-Glucuronyltransferase (UGT) 1A1

Release Time:2024-09-03  Hits:

Indexed by: Journal Papers

Document Code: 393213

Date of Publication: 2024-01-01

Journal: CURRENT DRUG METABOLISM

Volume: 25

Issue: 3

Page Number: 197-204

ISSN: 1389-2002

Key Words: CLEARANCE; ENZYME; GLUCURONIDATION; HEPATOTOXICITY; HUMAN LIVER; MICROSOMES; PREDICTION; PROBES; SELECTIVITY; SUBSTRATE

Prev One:Characterization of Dicaffeoylspermidine Derivatives from Wolfberry as Potent and Selective Inhibitors of Human Cytochrome P450 46A1 In vitro

Next One:Drug-drug interaction potentials of tucatinib inhibition of human UDP-glucuronosyltransferases